2m 2m 2m 2m 2m 2m 2m
IMPACT BIO (IBO)
NYSE
$0.48$0.00 (0.00%)
Price as of Aug 21, 2026 8:00 PM EDT- $51.8MMarket Cap
- -19.85%1-Year Change
- BiotechnologyIndustry
IMPACT BIO (IBO)
$0.48$0.00 (0.00%)
IBO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.48 | ||
Change | +$0.03 (+6.83%) | ||
Open | $0.44 | ||
High | $0.48 | ||
Low | $0.44 | ||
Previous Close | $0.45 | ||
Volume | 22,754 | ||
30-Day Average Volume | 29,882 | ||
1-Week Change | 4.51% | ||
1-Month Change | 8.84% | ||
1-Year Change | -19.85% | ||
3-Year Change | -98.07% | ||
5-Year Change | -98.07% | ||
Fundamentals | |||
Shares Outstanding | 107.8M | ||
Total Assets | $16.7M | ||
Market Cap | $51.8M | ||
Enterprise Value | $89.1M | ||
Period: QTR TTM FY | |||
Revenue | $3,000.00 | ||
Net Income | -$699,000.00 | ||
Free Cash Flow | $470,000.00 | ||
EBIT | -$699,000.00 | ||
EBITDA | -$415,000.00 | ||
Net Working Capital | -$1.7M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -215 | ||
Enterprise Value/Revenue | 29,699 | ||
P/B | 5 | ||
P/E | -48 | ||
PEG | -1 | ||
Price/Free Cash Flow | 110 | ||
Price/Operating Cash Flow | 110 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue